Discover 721 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 721
Active & ResponsiveNew
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
for
Monkeypox (Mpox)
Location: Lenexa KS, Ames IA, Fort Worth TX, Austin TX,
Sponsor: Bavarian Nordic
Sex: All
Age: 18 - 49
Code: NCT07199569
Phase2, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Lenexa KS, Kansas City MO, Springfield MO, Newton KS,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
for
Healthy Volunteers
Location: Lenexa KS
Sponsor: Karuna Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07118215
Phase1, Recruiting
Active & ResponsiveNew
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Kansas City KS, Dallas TX, Bloomington IN, Aurora CO,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: Olathe KS, Overland Park KS, Westwood KS,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants
for
Healthy Volunteers
Location: Lenexa KS
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18 - 60
Code: NCT06877702
Phase1, Recruiting
Active & Responsive
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age